跳至主要内容
临床试验/ISRCTN83972743
ISRCTN83972743已完成不适用

Autologous human bone marrow stem cells mobilized by granulocyte colony-stimulating factor (G-CSF) to improve liver function in patients with decompensated alcoholic liver disease: a randomized study

Foundation for Liver and Gut Studies (FLAGS) (Switzerland)0 个研究点目标入组 60 人开始时间: 2008年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18-75 years
  • 2. Biopsy-proven alcoholic liver disease
  • 3. Abnormal liver function with a Model for End-Stage Liver Disease (MELD) (assessment that include bilirubin, coagulation time and creatinine) score 10-26
  • 4. Written informed consent

排除标准

  • 1. Recent (10 days) infection or hemorrhage
  • 2. Estimated survival <6 months
  • 3. Coexistent HIV, hepatitis C virus (HCV), hepatitis B virus (HBV)
  • 4. Portal vein obstruction
  • 5. Documented hepatocellular carcinoma
  • 6. Severe liver atrophy as defined by volumetry <0.6% body weight
  • 7. Leucocytes >25g/L
  • 8. Known hypersensitivity to G-CSF
  • 9. Creatinine >150 µmol/L
  • 10. Contraindication to arteriography
  • 11. Clinically overt hepatic encephalopathy
  • 12. Absence of written consent

研究者

发起方
Foundation for Liver and Gut Studies (FLAGS) (Switzerland)

相似试验